EB-AMDK19 Trademark

Trademark Overview


On Monday, August 5, 2024, a trademark application was filed for EB-AMDK19 with the United States Patent and Trademark Office. The USPTO has given the EB-AMDK19 trademark a serial number of 79408656. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 24, 2025. This trademark is owned by Enterobiome Inc.. The EB-AMDK19 trademark is filed in the Pharmaceutical Products category with the following description:

Preparations of microorganisms for medical or veterinary use; pharmaceutical preparations for the treatment of autoimmune disorders; cultures of microorganisms for medical or veterinary use; pharmaceutical preparations for the prevention of autoimmune diseases; nutritional supplements; dietary supplements for humans; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of metabolic diseases, autoimmune diseases, hair loss, vaginitis, and menopause; probiotic supplements; probiotic preparations for medical use; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system.
eb-amdk19

General Information


Serial Number79408656
Word MarkEB-AMDK19
Filing DateMonday, August 5, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 24, 2025

Trademark Statements


Pseudo MarkEB AMDK ONE NINE
Goods and ServicesPreparations of microorganisms for medical or veterinary use; pharmaceutical preparations for the treatment of autoimmune disorders; cultures of microorganisms for medical or veterinary use; pharmaceutical preparations for the prevention of autoimmune diseases; nutritional supplements; dietary supplements for humans; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of metabolic diseases, autoimmune diseases, hair loss, vaginitis, and menopause; probiotic supplements; probiotic preparations for medical use; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system.
Pseudo MarkEB AMDK NINETEEN

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnterobiome Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR

Party NameEnterobiome Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Thursday, November 7, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, February 11, 2025ASSIGNED TO EXAMINER
Tuesday, February 18, 2025NON-FINAL ACTION WRITTEN
Wednesday, February 19, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 24, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 18, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 24, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 24, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, April 12, 2025REFUSAL PROCESSED BY IB
Monday, March 24, 2025REFUSAL PROCESSED BY MPU